OSMOTICA PHARMACEUTICALS PLC (OSMT) Stock Balance Sheet
NASDAQ:OSMT - Nasdaq - Common Stock
| MRQ (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.35M | 114.10M | 95.90M | 70.80M | 34.70M | |||
| Receivables | 4.19M | 26.40M | 43.90M | 56.40M | 37.60M | |||
| Inventories | 824.00K | 17.90M | 21.30M | 24.40M | 16.90M | |||
| Other Current Assets | 10.02M | 14.80M | 11.50M | 20.70M | 25.50M | |||
| Total Current Assets | 23.39M | 173.20M | 172.60M | 172.40M | 114.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.50M | 30.80M | 35.20M | 31.30M | 31.40M | |||
| Intangibles | 27.21M | 65.80M | 154.00M | 490.40M | 585.40M | |||
| Other Non-Current Assets | 603.00K | 400.00K | 600.00K | 800.00K | 900.00K | |||
| Total Non-Current Assets | 86.16M | 197.70M | 290.70M | 623.20M | 804.90M | |||
| TOTAL ASSETS | 109.55M | 370.90M | 463.30M | 795.60M | 919.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 29.93M | 0.00 | 100.00K | 1.90M | 6.70M | |||
| Accrued Expenses | 19.34M | 48.70M | 66.50M | 86.40M | 81.30M | |||
| Accounts Payable | 4.45M | 6.80M | 8.50M | 24.90M | 36.10M | |||
| Other Current Liabilities | 206.00K | 200.00K | 800.00K | 800.00K | 700.00K | |||
| Total Current Liabilities | 53.93M | 55.80M | 75.90M | 114.00M | 124.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 219.50M | 268.00M | 266.90M | 314.00M | |||
| Deferred Taxes/Income | 165.00K | 300.00K | 1.50M | 28.30M | 42.90M | |||
| Other Non-Current Liabilities | 702.00K | 1.40M | 3.10M | 2.50M | 2.40M | |||
| Total Non-Current Liabilities | 867.00K | 221.30M | 272.60M | 297.80M | 359.30M | |||
| TOTAL LIABILITIES | 54.80M | 277.10M | 348.50M | 411.80M | 484.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -497.81M | -452.60M | -373.00M | -102.10M | 0.00 | |||
| Additional Paid In Capital | 554.16M | 548.10M | 489.40M | 487.30M | 0.00 | |||
| Common Shares | 631.00K | 600.00K | 500.00K | 500.00K | 436.40M | |||
| Other Shareholders' Equity | -2.23M | -2.20M | -2.20M | -1.80M | -600.00K | |||
| Shares Outstanding | 63.13M | 62.50M | 51.80M | 52.50M | 51.20M | |||
| Tangible Book Value per Share | -0.45 | -1.16 | -2.70 | -3.95 | -15.10 | |||
| Total Shareholders' Equity | 54.75M | 93.90M | 114.70M | 383.80M | 435.80M | |||
| TOTAL LIABILITIES AND EQUITY | 109.55M | 370.90M | 463.30M | 795.60M | 919.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 2.34 | 2.34 | 0.70 | 0.72 | |||
| Current Ratio | 0.43 | 3.10 | 2.27 | 1.51 | 0.92 | |||
| Return On Assets (ROA) | -100.12% | -21.46% | -58.47% | -13.79% | -4.47% | |||
| Return On Equity (ROE) | -200.33% | -84.77% | -236.18% | -28.58% | -9.43% | |||
| Return On Invested Capital (ROIC) | N/A | 0.45% | 0.61% | 0.66% | 2.09% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 0.71% | 0.81% | 0.74% | 2.18% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 1.05% | 1.72% | 3.74% | 9.49% | |||
All data in USD , ROIC based on taxRate of 0.21